552 papers
Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.
At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.
Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.
This study identifies the host AAA+ ATPase RUVBL1/2 as a critical, specific factor for rhinovirus replication and demonstrates that its pharmacological inhibition effectively blocks the virus in human nasal epithelium models without inducing resistance, highlighting it as a promising antiviral target.
This study characterizes *Massilia varians* isolate P2-4, a safe and effective facultative predator with broad-spectrum bacteriolytic activity, as a novel biocontrol agent against pathogenic *Pseudomonas aeruginosa* in Chinese mitten crab (*Eriocheir sinensis*) aquaculture.
This study establishes live ratiometric calcium imaging in the oomycete pathogen *Phytophthora palmivora* using the MatryoshCaMP8s biosensor to reveal that polarized Ca2+ transients are recurrent signatures of developmental transitions and early host colonization.
This proof-of-concept study demonstrates that combining smartphone-coupled phase contrast microscopy with deep transfer learning can achieve preliminary, low-cost discrimination of Candida species, correctly identifying three out of four tested species with high recall using a small clinical isolate panel.
The compact type III-A Druantia defense system in bacteria clears phage infections by utilizing the DruE helicase to recognize exposed single-stranded DNA and unwind it in a 3'-to-5' direction, a process regulated by the dissociation of the DruH protein upon infection.
The authors developed CandiChrome, a versatile seven-fluorophore toolkit that enables the simultaneous tracking of up to 21 distinct *Candida albicans* populations in both in vitro and in vivo murine infection models, addressing a critical gap in multicolor imaging tools for this pathogenic fungus.
This study reveals significant strain-specific heterogeneity in *Fusobacterium nucleatum* virulence and indole production among clinical isolates, demonstrating that indole derivatives can differentially inhibit biofilm formation and cancer cell invasion while offering a potential pathway for precision therapeutic targeting of pathogenic strains without harming beneficial commensals.
Researchers discovered potent, orally bioavailable, non-covalent inhibitors of the Zika virus NS2B-NS3 protease through a fragment-based drug design approach, demonstrating significant efficacy in reducing viral loads in a murine infection model.
This study demonstrates that a three-phage combination effectively reduces actively replicating *Mycobacterium tuberculosis* loads and prevents regrowth in planktonic cultures, but exhibits limited antimycobacterial activity against non-replicating bacteria found in disease-relevant hypoxic and acidic conditions, highlighting the necessity of bacterial replication for phage lytic efficacy.
This study demonstrates that a specific human histone H1.2 peptide fragment exhibits potent, non-toxic antibacterial activity against *Pseudomonas aeruginosa* by disrupting outer membrane protein biogenesis and forming NET-like structures, suggesting its potential as a novel therapeutic agent against antimicrobial resistance.